Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/2HywUkgDVt
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/zBM0uDtUXu
CV Events Among Adults Treated With CAR T-Cell Therapy. Original Article (https://t.co/U59pCcGc55), Editorial Comment (https://t.co/A5yjlItt6s)and JACC Council Perspectives (https://t.co/STdv5r5uIu) #cardiotwitter #Oncology https://t.co/bXMDNLOBTA
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
@cardiooncCMB
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
RT @JACCJournals: As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will bec…
As CAR T-cell therapy evolves to include more patients, risk stratification & prompt treatment of cardiotoxicity will become more important. Drs. @AnaBaracCardio @JLiu_MSKCardOnc and colleagues share their expertise in this #JACC State-of-the-Art Revie
RT @CARTTherapy: #CART Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Co... https://t.co/svjFAo6YDn
#CART Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Co... https://t.co/svjFAo6YDn
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
Cardiac injury and CV events are 28% and 21% of the tested pts. This is very comparable to what we see in BMT given that the median age is 62 yo.
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
CAR T-Cell Rx for Cancer and Heart. CAR T-cell Rx is asso with potentially life-threatening adverse effects due to CRS. Clinical CVS manifestations include tachycardia, hypotension, troponin elevation, reduced LVEF, pulmonary edema, and cardiogenic shock.
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
RT @JACCJournals: #JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effect…
#JACC State-of-the-Art Review: CAR T-cell therapy can help treat certain malignancies, but it's also associated w/ effects from cytokine release syndrome. How do we combat these risks? Drs. @AnaBaracCardio, @JLiu_MSKCardOnc and team provide an overview. ht
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @JLiu_MSKCardOnc: Great podcast summary by Dr. Fuster. Look forward to lectures by coauthors @DrMiguelPerales @AnaBaracCardio and panel…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @KanelidisMD: #CardioOnc #CART cell therapy #CVD @NirUrielMD @gtsayer https://t.co/SCZQqAzJEp
#CardioOnc #CART cell therapy #CVD @NirUrielMD @gtsayer
Congrats @SarjuGanatraMD. This is great work.
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @DrThomasRyan: More important work from the ACC Cardio-oncology section. Great group to work with. https://t.co/L5zio2OlVn
More important work from the ACC Cardio-oncology section. Great group to work with.
RT @JLiu_MSKCardOnc: Great podcast summary by Dr. Fuster. Look forward to lectures by coauthors @DrMiguelPerales @AnaBaracCardio and panel…
RT @avirupguha: Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/BP80Pi985M excellent review in @JACCJournals by…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @JLiu_MSKCardOnc: Great podcast summary by Dr. Fuster. Look forward to lectures by coauthors @DrMiguelPerales @AnaBaracCardio and panel…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @datsunian: See our @JACC #cardioonc Section Council Perspectives Paper on CAR-T, a radical, relatively new cancer tx for refractory/rel…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @JLiu_MSKCardOnc: Great podcast summary by Dr. Fuster. Look forward to lectures by coauthors @DrMiguelPerales @AnaBaracCardio and panel…
RT @datsunian: See our @JACC #cardioonc Section Council Perspectives Paper on CAR-T, a radical, relatively new cancer tx for refractory/rel…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @datsunian: See our @JACC #cardioonc Section Council Perspectives Paper on CAR-T, a radical, relatively new cancer tx for refractory/rel…
RT @JLiu_MSKCardOnc: Great podcast summary by Dr. Fuster. Look forward to lectures by coauthors @DrMiguelPerales @AnaBaracCardio and panel…
RT @JLiu_MSKCardOnc: Great podcast summary by Dr. Fuster. Look forward to lectures by coauthors @DrMiguelPerales @AnaBaracCardio and panel…
Great podcast summary by Dr. Fuster. Look forward to lectures by coauthors @DrMiguelPerales @AnaBaracCardio and panel discussion on CV considerations in #CART at #MSKCardioOncCME @MSKCME @DLenihanICOS_MD @Dr_Mike_Fradley @sdent_duke @ICOSociety
CART Cell therapy and CRS. https://t.co/9NxwsRgbJL https://t.co/r7ecUoegeV
RT @datsunian: See our @JACC #cardioonc Section Council Perspectives Paper on CAR-T, a radical, relatively new cancer tx for refractory/rel…
RT @SarjuGanatraMD: CV evaluation before CART https://t.co/W3ve7rt4NQ https://t.co/a8AeV6lK5O
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
RT @SarjuGanatraMD: Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care du…
CV evaluation before CART https://t.co/a8AeV6lK5O
Our paper on #CART therapy for cancer and its CV impact. Mechanism, CV evaluation before CART, monitoring and care during therapy and role of #cardioonc in CART. Thank you @AnaBaracCardio @DLenihanICOS_MD @DrThomasRyan @datsunian @vgzmd @JLiu_MSKCardOnc
RT @datsunian: See our @JACC #cardioonc Section Council Perspectives Paper on CAR-T, a radical, relatively new cancer tx for refractory/rel…
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart | JACC: Journal of the American College of Cardiology CV event risk in CAR-T therapy https://t.co/3doeDJPoea
RT @datsunian: See our @JACC #cardioonc Section Council Perspectives Paper on CAR-T, a radical, relatively new cancer tx for refractory/rel…
See our @JACC #cardioonc Section Council Perspectives Paper on CAR-T, a radical, relatively new cancer tx for refractory/relapsed heme malignancies, that warrants further study on how to appropriately ID mechanisms, dx &manage CV toxicities/complicatio
RT @avirupguha: Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/BP80Pi985M excellent review in @JACCJournals by…
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/2HywUkgDVt
RT @avirupguha: Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/BP80Pi985M excellent review in @JACCJournals by…
RT @avirupguha: Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/BP80Pi985M excellent review in @JACCJournals by…
RT @avirupguha: Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/BP80Pi985M excellent review in @JACCJournals by…
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart https://t.co/BP80Pi985M excellent review in @JACCJournals by @SarjuGanatraMD @AnaBaracCardio @JLiu_MSKCardOnc and colleagues #cardioonc